These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22702645)

  • 1. Soluble CD40L in children and adolescents with type 1 diabetes: relation to microvascular complications and glycemic control.
    El-Asrar MA; Adly AA; Ismail EA
    Pediatr Diabetes; 2012 Dec; 13(8):616-24. PubMed ID: 22702645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of serum levels of soluble CD40L in Egyptian children and adolescents with type 1 diabetes mellitus: Relationship to microalbuminuria and glycemic control.
    Metwalley KA; Farghaly HS; El-Saied AR
    Indian J Endocrinol Metab; 2013 Nov; 17(6):1024-9. PubMed ID: 24381879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control.
    Metwalley KA; Raafat DM; Tamer DM; Farghaly HS; Said GM
    Arch Endocrinol Metab; 2021 May; 64(6):720-725. PubMed ID: 34033281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
    Chiarelli F; Giannini C; Verrotti A; Mezzetti A; Mohn A
    Diabetes Metab Res Rev; 2008 Oct; 24(7):570-6. PubMed ID: 18756582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.
    El-Asrar MA; Andrawes NG; Ismail EA; Salem SM
    Vasc Med; 2015 Dec; 20(6):509-17. PubMed ID: 26091968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome.
    Unek IT; Bayraktar F; Solmaz D; Ellidokuz H; Yuksel F; Sisman AR; Yesil S
    Metabolism; 2010 Mar; 59(3):305-13. PubMed ID: 20006362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
    Cipollone F; Chiarelli F; Davì G; Ferri C; Desideri G; Fazia M; Iezzi A; Santilli F; Pini B; Cuccurullo C; Tumini S; Del Ponte A; Santucci A; Cuccurullo F; Mezzetti A
    Diabetologia; 2005 Jun; 48(6):1216-24. PubMed ID: 15868137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial monocyte activating polypeptide II in children and adolescents with type 1 diabetes mellitus: Relation to micro-vascular complications.
    Adly AAM; Ismail EA; Tawfik LM; Ebeid FSE; Hassan AAS
    Cytokine; 2015 Dec; 76(2):156-162. PubMed ID: 26142824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients.
    Katakami N; Kaneto H; Matsuhisa M; Miyatsuka T; Sakamoto K; Kawamori D; Yoshiuchi K; Nakamura Y; Kato K; Yamamoto K; Kosugi K; Hori M; Yamasaki Y
    Diabetologia; 2006 Jul; 49(7):1670-6. PubMed ID: 16752185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
    Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A
    J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating angiopoietin-2 levels in children and adolescents with type 1 diabetes mellitus: relation to carotid and aortic intima-media thickness.
    El-Asrar MA; Elbarbary NS; Ismail EA; Bakr AA
    Angiogenesis; 2016 Jul; 19(3):421-31. PubMed ID: 27236773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
    Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
    Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Diabet Med; 2008 Nov; 25(11):1283-8. PubMed ID: 19046217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
    Sherif EM; El Maksood AAA; Youssef OI; Salah El-Din NY; Khater OKM
    J Diabetes Complications; 2019 Sep; 33(9):628-633. PubMed ID: 31301955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
    Williams KV; Becker DJ; Orchard TJ; Costacou T
    J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
    Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
    Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.
    Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D
    Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.